back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-09-18 14:39 Tx date 2019-09-13 |
$KLY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$26,306
+526,120 vol $0.05 each |
526,120 | |
| Filed 2019-09-18 14:38 Tx date 2016-12-30 |
$KLY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-09-18 14:38 Tx date 2019-09-13 |
$KLY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$26,306
+526,120 vol $0.05 each |
590,561 | |
| Filed 2019-09-18 14:36 Tx date 2019-09-13 |
$KLY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$98,647
+1,972,950 vol $0.05 each |
1,972,950 | |
| Filed 2019-09-18 14:34 Tx date 2016-12-30 |
$KLY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-09-18 14:34 Tx date 2019-09-13 |
$KLY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$98,647
+1,972,950 vol $0.05 each |
1,972,950 | |
| Filed 2019-09-18 14:33 Tx date 2016-12-30 |
$KLY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-24 15:09 Tx date 2019-06-19 |
$KLY
Kalytera Therapeutics, Inc. |
Hutchison, Robin Bruce
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
| Filed 2019-06-24 15:08 Tx date 2019-06-19 |
$KLY
Kalytera Therapeutics, Inc. |
Hutchison, Robin Bruce
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-24 10:03 Tx date 2019-06-19 |
$KLY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+68,698 vol |
4,209,781 | |
| Filed 2019-06-24 10:02 Tx date 2019-06-19 |
$KLY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,095,907 vol |
24,966,756 | |
| Filed 2019-06-24 10:01 Tx date 2019-06-19 |
$KLY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,095,907 vol |
||
| Filed 2019-06-24 10:00 Tx date 2019-06-19 |
$KLY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+254,345 vol |
4,015,963 | |
| Filed 2019-06-24 09:57 Tx date 2019-06-19 |
$KLY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,095,907 vol |
24,966,756 | |
| Filed 2019-06-24 09:57 Tx date 2019-06-19 |
$KLY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,095,907 vol |